Craneware plc AGM Statement (6582W)
11 Novembre 2014 - 8:01AM
UK Regulatory
TIDMCRW
RNS Number : 6582W
Craneware plc
11 November 2014
Craneware plc
("Craneware" or the "Company")
AGM Statement
11 November 2014 - Craneware plc (AIM: CRW.L), the market leader
in automated revenue integrity solutions for the US healthcare
market, will be holding its Annual General Meeting at 10am today at
the UK offices of Craneware plc, 1 Tanfield, Edinburgh, EH3 5DA. At
the meeting, Keith Neilson, CEO of the Company, will make the
following statement:
"We have benefited from the positive sales momentum of the prior
year continuing into this current year. The accrued revenue balance
from the guaranteed minimum revenues associated to a partner deal
which peaked during FY14 has been substantially cleared; this
combined with the sales levels experienced has contributed to
strong levels of cash collection in the first quarter. Further, the
Company has completed two equity transactions, the first being the
share 'buy-back' and the second being the acquisition of the
emerging technology company, Kestros Limited. Kestros provides a
platform in the high growth Patient Access market, as the Company
addresses the growing level of consumerisation within
healthcare."
"We remain focused on the execution of our growth strategy and
look forward to continuing to grow shareholder value in the year
ahead."
For further information, please contact:
Craneware plc Peel Hunt Newgate Threadneedle
+44 (0)131 550 +44 (0)20 7418
3100 8900 +44 (0)20 7653 9850
Keith Neilson, Dan Webster Tim Thompson
CEO
Craig Preston, Richard Kauffer Heather Armstrong
CFO Edward Treadwell
About Craneware
Founded in 1999, Craneware has headquarters in Edinburgh,
Scotland with offices in Georgia, Arizona, Massachusetts and
Tennessee employing over 200 staff. Craneware is the leader in
automated revenue integrity solutions that improve financial
performance for healthcare organisations. Craneware's
market-driven, SaaS solutions help hospitals and other healthcare
providers more effectively price, charge, code and retain earned
revenue for patient care services and supplies. This optimises
reimbursement, increases operational efficiency and minimises
compliance risk. By partnering with Craneware, clients achieve the
visibility required to identify, address and prevent revenue
leakage. To learn more, visit craneware.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMDGBDBSUBBGSG
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024